Using big data to retrospectively validate the COMPASS-CAT risk assessment model: considerations on methodology

Ilias Nikolakopoulos1, Soheila Nourabadi1, Joanna B Eldredge1

  • 1Department of Medicine, Anticoagulation and Clinical Thrombosis Services, The Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, The Feinstein Institute for Medical Research, Northwell Health at Lenox Hill Hospital, 130 E 77th St, New York, NY, USA.

Summary

This study details challenges in externally validating the COMPASS-CAT risk model for cancer-associated thrombosis using big data. It outlines methods to ensure reliable validation for clinical use.